Xvivo Perfusion AB (publ) (XVIPF)

Market Cap	753.42M +30.8%
Revenue (ttm)	92.37M +8.8%
Net Income	9.14M -20.5%
EPS	0.29 -20.0%
Shares Out	n/a
PE Ratio	82.45
Forward PE	53.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	30.95
Previous Close	25.01
Day's Range	25.01 - 30.95
52-Week Range	16.98 - 30.95
Beta	1.46
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 197
• Stock Exchange: OTCMKTS
• Ticker Symbol: XVIPF

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error